Home >> Top News >> Roche to acquire Viewics

Roche to acquire Viewics

Print Friendly, PDF & Email

Nov. 20, 2017Roche announced today it will acquire Viewics, a privately held software company focused on laboratory business analytics. This acquisition allows Roche to expand its position in the integrated core lab with business analytics capabilities, enabling laboratories to make faster, data-driven informed decisions on their operations and processes. The cloud-based solution is secure, infrastructure agnostic, interactive, and accessible from multiple devices, such as smart phones, tablets, and desktop computers.

“We are excited that Viewics, Inc., will be joining the Roche group, as it will help us to support our customers around the world in improving their lab performance and processes,” Roland Diggelmann, CEO Roche Diagnostics, said in a statement. “The Viewics solution offers our customers insights at their fingertips, uncovering potential value and profitability drivers in lab operations, and indicators to improve overall quality of care.”

The acquisition is expected to close Nov. 21.

More top news


Check Also

Roche to acquire Ignyta, 4/18

April 2018—Roche will acquire San Diego–based Ignyta for $27.00 per share in cash, or $1.7 billion. Ignyta, which will continue its operations in San Diego, focuses on precision medicine in oncology aiming to test, identify, and treat patients with cancers harboring specific rare mutations.